Furthermore, our study showed that CARM1 may be a crucial regulator of skeletal muscle atrophy and suggested that calycosin may be a potential therapy for skeletal muscle atrophy induced by CKD, malnutrition or other conditions. The gene discussed is CARM1; the disease is muscular atrophy.